Investigations and CAPA3 min readBy QLogixCMC
Why 21 CFR 211.192 stays the most-cited observation, and how a backlog really comes down
21 CFR 211.192 requires every unexplained discrepancy and every failure of a batch to meet its specifications to be thoroughly investigated, extended to other batches that may have been affected, and recorded with conclusions and follow-up. It has topped FDA's list of drug GMP observations for years because the failure is systemic rather than technical: too many open records, investigations that stop at human error, and CAPAs that are never checked. A backlog is arithmetic before it is anything else.
What the regulation asks for
- Review of all production and control records before a batch is released
- A thorough investigation of any unexplained discrepancy or any failure to meet specifications, whether or not the batch was distributed
- Extension of the investigation to other batches and products that may have been associated with the discrepancy
- A written record of the investigation, its conclusions and the follow-up
The three ways an investigation fails
- It stops at the symptom: a root cause of human error or operator retrained, with nothing that explains why the error was possible
- It stays inside the batch: the scope is never extended to the other batches, products and systems the cause could have touched
- It is late: the record stays open past the procedure's limit without a justified extension, and the next inspector reads the oldest ones first
Interactive
Will the backlog come down, and will the old records go first?
68still open at week 26
Falling by 2 a week; about 34 more weeks after that. 28 are older than 30 days.
- Open investigations
- Older than 30 days
- If closures only matched intake
Arithmetic first, then standard work
A backlog falls only while the site closes more records a week than it opens. Before any method, the question is capacity against intake, and the honest answers are more investigators for a season, fewer deviations through fixed recurring causes, or both. Closing records faster by lowering the standard is not an answer; it moves the problem to the inspection.
With the arithmetic right, the method matters: triage every open record by product impact and age, agree with the quality unit what a closed record has to contain, work the queue in risk order, and show the burn-down every week. Recurring causes get one CAPA with an effectiveness check, not twenty investigations with the same conclusion.
How QLogixCMC helps
QLogixCMC investigators take on a backlog within two weeks of the first call: triage in the first week, standard work and the burn-down in the second, then records closed in risk order with the site's own investigators coached on live records so the capability stays when the engagement ends.
Questions this post answers
How long should a deviation investigation take?
Most procedures set 30 days to closure with a documented, justified extension where more time is needed. The regulation asks for timeliness proportional to the risk; an investigation that could affect a distributed batch cannot wait for the monthly meeting.
Is human error ever an acceptable root cause?
Only once the investigation has shown why the error was possible: an unclear procedure, a step that invites it, a workload or a design. Human error as the stated cause with retraining as the CAPA is the pattern inspectors cite most.
More from the blog
- Technology transfer · Onshoring drug manufacturing: the tech transfer and validation path to a US site
- AI and digital quality · AI in the GMP quality system: what Annex 22 and your next inspector will ask
- Sterile manufacturing · Annex 1 three years on: the contamination control strategy inspectors now read first